Press "Enter" to skip to content

Axsome depression drug meets late-stage study goal, shares soar 56%

The trial results take the company a step closer to acquiring a share of the multi-billion dollar market for depression drugs.

Original source: https://health.economictimes.indiatimes.com/news/pharma/axsome-depression-drug-meets-late-stage-study-goal-shares-soar-56/72758247?utm_source=RSS&utm_medium=ETRSS

Also Read:   Lupin launches generic antidepressant tablets in US